🇺🇸 FDA
Patent

US 6649411

Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides

expired A61PA61P35/00

Quick answer

US patent 6649411 (Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P35/00